Abbott Laboratories [NYSE: ABT] closed the trading session at $6700000.0 on 2025-06-24. The day’s price range saw the stock hit a low of $132.4, while the highest price level was $139.05.
The stocks have a year to date performance of 29.57 percent and weekly performance of 3.04 percent. The stock has been moved at 23.36 percent over the last six months. The stock has performed 5.00 percent around the most recent 30 days and changed 8.54 percent over the most recent 3-months.
If compared to the average trading volume of 6.70M shares, ABT reached to a volume of 9894576 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Abbott Laboratories [ABT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABT shares is $142.87 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Abbott Laboratories shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on October 08, 2024, representing the official price target for Abbott Laboratories stock. Previously, the target price had yet another raise to $131, while Piper Sandler analysts kept a Overweight rating on ABT stock.
The Price to Book ratio for the last quarter was 4.92, with the Price to Cash per share for the same quarter was set at 3.93. Price to Free Cash Flow for ABT in the course of the last twelve months was 36.09 with Quick ratio for the last quarter at 1.27.
ABT stock trade performance evaluation
Abbott Laboratories [ABT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.04. With this latest performance, ABT shares gained by 5.00% in over the last four-week period, additionally plugging by 23.36% over the last 6 months – not to mention a rise of 22.08% in the past year of trading.
Abbott Laboratories [ABT]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Abbott Laboratories [ABT] shares currently have an operating margin of 16.96% and a Gross Margin at 51.42%. Abbott Laboratories’s Net Margin is presently recorded at 31.72%.
Return on Equity for this stock inclined to 17.45%, with Return on Assets sitting at 17.45%.
Earnings per share (EPS) analysis for Abbott Laboratories [ABT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbott Laboratories go to 10.36%.
Abbott Laboratories [ABT]: Institutional Ownership
There are presently around $80.53%, or 80.97% of ABT stock, in the hands of institutional investors. The top three institutional holders of ABT stocks are: VANGUARD GROUP INC with ownership of 166.35 million shares, which is approximately 9.5932%. BLACKROCK INC., holding 131.13 million shares of the stock with an approximate value of $$13.63 billion in ABT stocks shares; and BLACKROCK INC., currently with $$7.73 billion in ABT stock with ownership which is approximately 4.2903%.
